Shop

N-terminal Prohormone of Brain Natriuretic Reptide (NT-pro BNP) Rapid Test Kit for analyzers

899,00 PLN per package (25 pieces)

The product is designed for professional use with an analyzer.

In stock

 zł

Product description

NT-proBNP (heart failure) assay for BISAF analyzer (whole blood/serum/plasma) – 25pcs kit.

This kit is used for in vitro quantitative determination of N-terminal prohormone brain natriuretic peptide (NT-pro BNP) concentration in human whole blood, serum and plasma. This product is used for testing in medical and health care facilities as an aid to diagnosis and prognosis determination in heart failure.

The product is designed for professional use.

Properties

  • sample material: whole blood, serum or plasma
  • convenient collection of the test sample
  • high quality product
  • quick result in as little as 15 minutes!
  • required amount of blood for the sample: 30 μl
  • bulk packaging of 25 units
  • product designed for professional use

The package contains

  • chip for auto-calibration of the device.
  • 25 test cassettes
  • 25 sample dilution solutions
  • 25 alcohol-soaked swabs
  • 25 punctures
  • 25 droppers
  • instruction manual

Note: Do not mix items from sets of different series.

Test Application

The NT-proBNP test is helpful in diagnosing and assessing the severity of congestive heart failure. The test is performed when there are symptoms indicative of heart failure, such as shortness of breath and rapid fatigue, and in people being treated for heart failure. Heart failure detection test: ischemic heart disease, left ventricular failure, acute coronary syndromes

Currently, heart failure is diagnosed based on symptoms such as leg swelling, shortness of breath and easy fatigue, and on imaging studies: chest X-rays and ultrasound studies called echocardiography. Heart failure is often confused with other conditions. NT-proBNP testing can help distinguish heart failure from other diseases, such as lung disease. Proper diagnosis is important because treatment of heart failure is different from treatment of lung disease and should be started as soon as possible.